AzTrials
AzTrials

Implant or Graft; RejectionNCT03684954

Effect Of PRF Versus Xenograft In Closed Sinus Lift.

A study testing Prf in people with Implant or Graft; Rejection, run by Mahmoud adel shaaban.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Indirect sinus lift with used PRF as a graft material versus xenograft Read more about this study

Who is it for?
Ages 25 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Implant or Graft; Rejection
What is being tested?
Prf
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
No sites listed yet
Study dates
1 Oct 2018to 30 Aug 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Edentulous area and bone high at least 5-6 mm below the maxillary sinus at maxillary premolar.
  • Good oral hygiene.

Who cannot join

  • bad oral hygiene.
  • patient with systemic disease that may affect normal healing
  • pregnant patients.
  • patients with bone diseases and presence of periapical pathology affecting the neighboring teeth.
  • Heavy smoker more than 20 cigarettes per day

About this study

Official title: Prf Controlled, Randamized Clinical Trial of THE EFFECT OF PLATELET RICH FIBRIN( PRF ) VERSUS XENOGRAFT IN CLOSED SINUS LIFT AND IMLANT PLACEMENT ON IMPLANT STABILITY IN PATIENTS WITH MISSING MAXILLARY PREMOLAR.

Indirect sinus lift with used PRF as a graft material versus xenograft

Read the detailed description

Crestal incision and reflect the tissue until exposure of the bone, then use drilling to make osteotomy. Then use sutable osteotomes to elevate the sinus floor, then pack of Prf or bone graft in the osteotomy and implant placement . Then closed the flap and suturing.

Being tested
Prf
Medical subject headings
Rejection, Psychology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PrfOther

    Take 10 cc blood from patient and gain prf

Study groups in NCT03684954
Study groupRoleWhat they receive
Used of PRF in clsed sinus liftingOtherUsed of PRF in closed sinus lifting with implant placement
Receives: Other: Prf
Closed sinus with xenograftNo interventionused of xenograft in closed sinus lift with implant placement.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary stability by ostell device

    Implant stability will be mesured by ostell device, implant stability will be mesured intra operative at 0 ( time of implant placement ) and 2, 4, 6, 10 and 12 weeks after surgery

    Measured: up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2018
  2. Study start1 Oct 2018 (estimated)
  3. Primary completion30 Aug 2019 (estimated)
  4. Study completion30 Aug 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patallel Assignment
Masking
Single blind
Who is masked
Investigator
Enrolment
10 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03684954
Sponsor's protocol ID
Cairo Univ.
Status last verified
Sep 2018
First submitted
16 Sep 2018
Last updated
26 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Prf in people with Implant or Graft; Rejection, run by Mahmoud adel shaaban.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary stability by ostell device (time frame: up to 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in